
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
05/08/2025 | Q1 | -- | $56.6M | $1.67 | -- | -- |
02/13/2025 | Q4 | -- | $70.6M | $4.41 | -- | -- |
11/05/2024 | Q3 | -- | $68.8M | $4.92 | -- | -- |
08/06/2024 | Q2 | -- | $65.4M | $4.70 | -- | -- |
05/03/2024 | Q1 | -- | $53.5M | $2.40 | -- | -- |
02/13/2024 | Q4 | -- | $53.7M | $3.09 | -- | -- |
11/02/2023 | Q3 | -- | $61.4M | $3.75 | -- | -- |
08/07/2023 | Q2 | -- | $58.3M | $4.00 | -- | -- |
05/05/2023 | Q1 | -- | $51.3M | $0.62 | -- | -- |
02/14/2023 | Q4 | -- | $65.5M | $3.97 | -- | -- |
11/04/2022 | Q3 | -- | $78M | $4.17 | -- | -- |
08/05/2022 | Q2 | -- | $70.9M | $1.20 | -- | -- |
05/06/2022 | Q1 | -- | $69M | $3.25 | -- | -- |
02/14/2022 | Q4 | -- | $91M | $9.94 | -- | -- |
11/09/2021 | Q3 | -- | $81.4M | $7.63 | -- | -- |
08/04/2021 | Q2 | -- | $85M | $10.42 | -- | -- |
05/10/2021 | Q1 | -- | $72.1M | $7.29 | -- | -- |
02/15/2021 | Q4 | -- | $77.1M | $8.77 | -- | -- |
11/04/2020 | Q3 | -- | $67.6M | $8.07 | -- | -- |
08/04/2020 | Q2 | -- | $61.7M | $7.65 | -- | -- |
05/05/2020 | Q1 | -- | $29.9M | -$3.71 | -- | -- |
02/11/2020 | Q4 | -- | $52.9M | $6.00 | -- | -- |
11/04/2019 | Q3 | -- | $47.9M | $4.20 | -- | -- |
08/05/2019 | Q2 | -- | $42.7M | $2.90 | -- | -- |
05/03/2019 | Q1 | -- | $39.9M | $3.49 | -- | -- |
02/08/2019 | Q4 | -- | $32.3M | $0.07 | -- | -- |
11/02/2018 | Q3 | -- | $48.3M | $5.61 | -- | -- |
08/06/2018 | Q2 | -- | $41.9M | $3.66 | -- | -- |
05/08/2018 | Q1 | -- | $33.8M | $2.20 | -- | -- |
02/07/2018 | Q4 | -- | $40.6M | $5.08 | -- | -- |
11/02/2017 | Q3 | -- | $43.1M | $3.13 | -- | -- |
08/08/2017 | Q2 | -- | $40.1M | $2.99 | -- | -- |
05/08/2017 | Q1 | -- | $37.8M | $2.36 | -- | -- |
02/09/2017 | Q4 | -- | $38.8M | $2.67 | -- | -- |
11/02/2016 | Q3 | -- | $41M | $4.29 | -- | -- |
08/03/2016 | Q2 | -- | $33.8M | $2.35 | -- | -- |
05/03/2016 | Q1 | -- | $24.9M | $0.93 | -- | -- |
02/11/2016 | Q4 | -- | $28.9M | $1.12 | -- | -- |
11/02/2015 | Q3 | -- | $34.5M | $2.28 | -- | -- |
Investors Title reported $56.6M worth of top line sales in its most recent quarter.
Investors Title announced earnings per share of $1.67 which represents a beat of analyst forecast a -- per share.
Investors Title reported -- that represents -- per share over the last quarter.
Investors Title's earnings are forecast to grow from $16.43 per share to -- per share next year representing an increase of --.
Investors Title's next earnings date is August 6, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.